− Transaction Increases Scale and Enhances Access to Securitization Markets – − Synergistic Expansion Expected to Drive Earnings Accretion and Long-Term Growth −
− Transaction Increases Scale and Enhances Access to Securitization Markets – − Synergistic Expansion Expected to Drive Earnings Accretion and Long-Term Growth −
Valuation of $4.7 billion driven by 10% organic growth
Investment to support Bain Capital-backed partnership's growth and M&A strategy
Brown Gibbons Lang & Company (BGL), a leading investment banking and financial advisory firm, is pleased to announce the closing of the acquisition of a majority stake in Cardioline, a European cardiology diagnostics company and the European leader in cardiology-focused telemedicine, by ArchiMed, a trans-Atlantic private equity firm specializing in healthcare. BGL’s Healthcare & Life Sciences team initiated the transaction and acted as the exclusive financial advisor to Cardioline. The specific terms of the transaction were not disclosed. Founded in 1962...